Tian An Medicare Limited (COLRF) Fair Value & Analysis
Healthcare · US · Market cap $80.8M
Fair value as of: Jun 26, 2026
Analysis
Tian An Medicare Limited (COLRF) currently trades at $0.0800, while our model-based Fair Value estimate is $0.1040 — implying the stock looks roughly 30.0% undervalued today. We read business quality at 92/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
About the company
Tian An Medicare Limited, an investment holding company, primarily operates hospitals in the People's Republic of China and Hong Kong. It operates through Healthcare, Eldercare, Property Development, Property Investment, Financial Services, and Securities Trading and Investments segments. The company is also involved in property development of independent living units and project management of health campus with a focus on eldercare and retirement community including elderly nursing home, service apartments, independent living units and commercial area comprising shopping mall, retail shops, and club hall facilities. In addition, it develops and sells properties and lands; leases properties; and provides loan financial and healthcare services, as well as trading of securities listed in overseas exchange. The company was formerly known as China Medical & HealthCare Group Limited and changed its name to Tian An Medicare Limited in April 2024. Tian An Medicare Limited was incorporated …
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Tian An Medicare Limited (COLRF) undervalued?
What is the fair value of COLRF?
What is the quality score of COLRF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.